Lymphoid Malignancy Flashcards

1
Q

What is lymphoma?

A
  • cancers of lymphoid origin
  • lymphadenopathy
  • extranodal involvement
  • bone marrow involvement
  • systemic symptoms
  • weight loss (> 10% in 6 months)
  • fever
  • night sweats
  • pruritis
  • fatigue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How is lymphoma diagnosed?

A
  • defined by the malignanct cell characteristics (50 entities)
  • biopsy
  • staging- clinical examination + imaging
  • location + extent
  • prognosis
  • treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is Hodgkin and non-Hodgkin lymphoma?

A
  • Hodgkin- specific disease
  • non-Hodgkin- everything else (~70 subtypes)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are some lymphoproliferative disorders?

A
  • acute lymphoblastic leukaemia (ALL)
  • chronic lymphocytic leukaemia (CLL)
  • Hodgkin lymphoma
  • non-Hodgkin lymphoma (NHL)
  • high-grade (diffuse large B-cell lymphoma)
  • low-grade (follicular, marginal zone)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is acute lymphoblastic leukaemia (ALL)?

A
  • cancerous disorder of lymphoid progenitor cells
  • normal- immature, rapidly proliferating cells that differentiate into lymphocytes
  • leukaemia- no differentiation, rapid, uncontrolled growth + accumulation
  • usually in bone marrow but can go anywhere
  • 1-2/100,000 per year
  • 75% cases < 6 yrs
  • 75-90% cases B-cell lineage
  • 2-3 week history of bone marrow failure or bone/joint pain
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the presentations of acute lyphoblastic leukaemia (ALL)?

A
  • bone marrow failure
  • inc. WCC
  • bone pain
  • infection
  • sweats
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are investigations for acute lymphoblastic leukaemia (ALL)?

A
  • Hb (low)
  • WCC (high)
  • platelets (low)
  • bone marrow
  • 90% B-lymphoblasts
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are acute lymphoblastic leukamaemia (ALL) cell characteristics?

A
  • large cells
  • express CD19
  • CD34, TDT (markers of very early, immature cells)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the treatment for acute lymphoblastic leukaemia (ALL)?

A
  • chemotherapy
  • consolidation therapy
  • CNS directed treatment
  • 18 months
  • stem cell transplantation (if high risk)
  • Bi-specific T-cell engagers (BiTe molecules) (blinatumumab)
  • chimeric antigen receptor T-cells (CAR)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the process of CAR therapy?

A
  • patient/healthy 3rd party T-cells harvested
  • transfected to express a specific T-cell receptor expressed on leukaemia cells (CD19)
  • expanded in-vitro
  • reinfused into patient
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the key side effects of T-cell immunotherapy?

A
  • cytokine release syndrome
  • fever, hypotension, dyspnoea
  • effect of CAR correlates with CRS presence- significant number require ITU support
  • neurotoxicity
  • confusion, with normal concious level
  • seizure, headache, focal neurology, coma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are risk factors for a poor prognosis in acute lymphoblastic leukaemia (ALL)?

A
  • inc. age
  • inc. WCC
  • cytogenetic/molecular genetics
  • t(9;22), t(4;11)
  • slow/poor response to treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the outcome of acute lymphoblastic leukaemia (ALL)?

A

Adults:

  • ~90% complete remission rate
  • 30-35% leukaemia-free survuval at 5 yr

Children:

  • 90% overall survival
  • 45% 5 yr survival, poor risk patients (slow reponse or Philadelphia +ve)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is chronic lymphocytic leukaemia (CLL)?

A
  • abnormal cells are mature
  • grow slowly, or no growth
  • low-grade condition
  • carry many normal markers that B lymphocytes have
  • lymphocyte count > 5 (normal < 4)
  • > 1700 new cases per yr in UK
  • M:F, 2:1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the presentations of chronic lymphocytic leukaemia (CLL)?

A
  • often asymptomatic
  • bone marrow failure
  • anaemia, thrombocytopenia
  • lymphadenopathy
  • splenomegaly
  • fever
  • sweats

Less common:

  • hepatomegaly
  • infections
  • weight loss
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are features of chronic lymphocytic anaemia (CLL)?

A
  • immune paresis
  • haemolytic anaemia
  • 20% +ve direct antiglobulin test
  • 8% clinical evidence of haemolytic anaemia
17
Q

What is chronic lymphocytic leukaemia (CLL) Binet staging?

A
18
Q

What are indications for treatment in chronic lymphocytic leukaemia (CLL)?

A
  • progressive bone marrow failure
  • massive lymphadenopathy
  • progressive splenomegaly
  • lymphocyte doubling time < 6 months OR 50% inc. over 2 months
  • systemic symptoms
  • autoimmune cytopenias
19
Q

What is the treatment for chronic lymphocytic leukaemia (CLL)?

A
  • often nothing
  • ‘watch + wait’
  • cytotoxic chemotherapy
  • e.g. fludarabine, bendamustine
  • monoclonal antibodies
  • e.g. rituximab, obinatuzumab
  • novel agents
  • bruton tyrosine kinase inhibitors, e.g. ibrutinin
  • PI3K inhibitors, e.g. idelalisib
  • BCL-2 inhibitor, e.g. venetoclax
20
Q

What are risk factors for a poor prognosis in chronic lymphocytic leukaemia (CLL)?

A
  • advanced disease (Binet stage B/C)
  • atypical lymphocyte morphology
  • rapid lymphocyte doubling time (< 12 months)
  • CD38+ expression
  • loss/mutation p53; del 11q23 (ATM gene)
  • unmutated IgVH gene status
21
Q

What are the presentations of lymphoma?

A
  • lymphadenopathy.hepatosplenomegaly
  • extranodal disease
  • “B symptoms”
  • bone marrow involvement
22
Q

What are the investigations and staging for lymphoma?

A
  • lymph node biopsy
  • CT scan
  • bone marrow aspirate
  • trephine
23
Q

What are the four stages of lymphoma?

A
  • stage I- localised disease, single lymph node region or single organ
  • stage II- 2 or more lymph node regions on the same side of the diaphragm
  • stage III- 2 or more lymph node regions above + below the diaphragm
  • stage IV- widespread disease; multiple organs, with or without lymph node involvement
24
Q

How is non-Hodgkin lymphoma classified?

A
  • lineage (B-cell or T-cell)
  • majority B-cell (90%)
  • “grade”
  • high grade- agressive fast growing, require combination chemotherapy, can be cured
  • low grade- indolent often asymptomatic, responds to chemotherapy bbubt incurable
25
Q

What are specific disease entities of non-Hodgkin lymphoma?

A
  • dissuse large B-cell lymphoma
  • commonest lymphoma
  • high grade lymphoma
  • follicular lymphoma
  • 2nd commonest lymphoma
  • low-grade lymphoma
  • ‘watch + wait’ if no issues
  • both treated with combination chemotherapy
  • anti-CD20 monoclonal antibody + chemotherapy
26
Q

What are features of Hodgkin lymphoma?

A
  • 30% of all lymphoma
  • 15-35 yrs + later in life
  • M:F, 1.9:1
  • association with; Epstein Barr virus, familial, geographical clustering
27
Q

What is the treatment for Hodgkin lymphoma?

A
  • combination chemotherapy (ABVD)
  • +/- radiotherapy
  • monoclonal antibodies (anti-CD30)
  • immunotherapy (checkpoint inhibitors)
  • PET scan assess response to treatment